PMID- 36725746 OWN - NLM STAT- MEDLINE DCOM- 20231027 LR - 20231027 IS - 1573-4978 (Electronic) IS - 0301-4851 (Linking) VI - 50 IP - 4 DP - 2023 Apr TI - Low concentrations of tumor necrosis factor-alpha promote human periodontal ligament stem cells osteogenic differentiation by activation of autophagy via inhibition of AKT/mTOR pathway. PG - 3329-3339 LID - 10.1007/s11033-022-08173-8 [doi] AB - BACKGROUND: Tumor necrosis factor-alpha (TNF-alpha) is one of the crucial inflammatory factors in alveolar bone metabolism during the process of periodontitis. Autophagy is indispensable for proper osteoblast function. However, the effects of autophagy on osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs) in inflammatory microenvironment and the underlying mechanisms remain to be clarified. The aim of the present study was to investigate whether autophagy participates in hPDLSCs differentiation after treated with TNF-alpha and explore the underlying mechanisms. METHODS AND RESULTS: Characterizations of hPDLSCs were evaluated by Alizarin-red S staining, Oil red staining and flow cytometry. hPDLSCs were treated with various concentrations of TNF-alpha. Rapamycin or 3MA was used to achieve or inhibit autophagy activation. AKT signaling was inhibited using ARQ092. Cell proliferation was evaluated using Cell Counting Kit-8 (CCK8) assay. Real-time reverse transcriptase-polymerase chain reaction assay (RT-PCR), western blot, alkaline phosphatase (ALP) staining and Alizarin Red S staining were applied to evaluate levels of osteogenic differentiation and autophagy. CCK8 showed that low concentrations of TNF-alpha had no influence on cell proliferation, while high concentrations of TNF-alpha inhibited proliferation. Low concentrations of TNF-alpha promoted osteogenic differentiation and autophagy, while high concentrations of TNF-alpha inhibited osteogenic differentiation and autophagy in hPDLSCs. The levels of osteogenic differentiation in hPDLSCs were partly effected after co-incubation with 0.1 ng/mL TNF-alpha with 3MA or Rapamycin. ARQ092 enhanced 0.1 ng/mL TNF-alpha-induced ALP expression and mineral nodule formation. CONCLUSION: Low concentrations of TNF-alpha promote hPDLSCs osteogenic differentiation by activation of autophagy via inhibition of AKT/mTOR signaling. CI - (c) 2023. The Author(s), under exclusive licence to Springer Nature B.V. FAU - Yuping, Qi AU - Yuping Q AUID- ORCID: 0000-0002-8921-6320 AD - Department of Oral Medicine, Qilu Hospital of Shandong University, Wenhua West Road 107, 250012, Jinan, China. AD - Institute of Stomatology, Shandong University, Jinan, China. FAU - Yijun, Luan AU - Yijun L AUID- ORCID: 0000-0002-6590-9229 AD - Department of Oral Medicine, Qilu Hospital of Shandong University, Wenhua West Road 107, 250012, Jinan, China. AD - Institute of Stomatology, Shandong University, Jinan, China. FAU - Limei, Wang AU - Limei W AUID- ORCID: 0000-0002-5041-2287 AD - Department of Oral Medicine, Qilu Hospital of Shandong University, Wenhua West Road 107, 250012, Jinan, China. sdkqwlm@163.com. AD - Institute of Stomatology, Shandong University, Jinan, China. sdkqwlm@163.com. LA - eng GR - ZR2019BH081/Natural Science Foundation of Shandong Province/ PT - Journal Article DEP - 20230201 PL - Netherlands TA - Mol Biol Rep JT - Molecular biology reports JID - 0403234 RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Humans MH - Cell Differentiation/genetics MH - Cell Proliferation MH - Cells, Cultured MH - *Osteogenesis/genetics MH - *Periodontal Ligament/metabolism MH - *Proto-Oncogene Proteins c-akt/genetics/metabolism MH - *Stem Cells MH - *TOR Serine-Threonine Kinases/genetics/metabolism MH - *Tumor Necrosis Factor-alpha/genetics/metabolism MH - Autophagy/genetics OTO - NOTNLM OT - AKT/mTOR pathway OT - Autophagy OT - Osteogenic differentiation OT - TNF-alpha OT - hPDLSCs EDAT- 2023/02/02 06:00 MHDA- 2023/03/29 06:05 CRDT- 2023/02/01 23:14 PHST- 2022/07/29 00:00 [received] PHST- 2022/12/01 00:00 [accepted] PHST- 2023/03/29 06:05 [medline] PHST- 2023/02/02 06:00 [pubmed] PHST- 2023/02/01 23:14 [entrez] AID - 10.1007/s11033-022-08173-8 [pii] AID - 10.1007/s11033-022-08173-8 [doi] PST - ppublish SO - Mol Biol Rep. 2023 Apr;50(4):3329-3339. doi: 10.1007/s11033-022-08173-8. Epub 2023 Feb 1.